Consulting Excellence in
Strategy Growth Innovation
For centuries, Hong Kong has been a bridge between the East and West. This position has never been more relevant as the US and China become the two largest and most important markets for biomedical companies. Let us be your eyes and ears, boots on the ground in Hong Kong. Whether you are a global company seeking to access the Chinese market, or a Chinese company looking to expand globally, let us help you:
- Leverage Hong Kong as a clinical trial, R&D, and logistics node
- Formulate your China launch & globalization strategy
- Develop business opportunities within the Greater Bay Area biomedical ecosystem
- Integrate with the broader ecosystem of Tigermed
- Apply for grants and subsidies from the Hong Kong Government and other sources
- Set up offshore corporate entities, VIE structures, bank accounts, and visa packages
- Utilize Hong Kong as a test market to identify product-market fit
- Identify potential assets for licensing and collaboration
- Engage with potential investors, brokers, and strategic partners
